Technical Analysis for EW - Edwards Lifesciences Corporation

Grade Last Price % Change Price Change
D 84.8 -1.71% -1.48
EW closed up 0.59 percent on Tuesday, March 2, 2021, on 1.37 times normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Flat
Historical EW trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish -1.72%
MACD Bullish Signal Line Cross Bullish -1.72%
Crossed Above 20 DMA Bullish -1.13%
Down 3 Days in a Row Weakness 2.05%
20 DMA Resistance Bearish 0.99%
Fell Below 20 DMA Bearish 0.41%
180 Bearish Setup Bearish Swing Setup 0.41%
Crossed Above 20 DMA Bullish -0.49%
Outside Day Range Expansion -0.49%
20 DMA Resistance Bearish 0.58%
Older End-of-Day Signals for EW ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Fell Below 20 DMA 11 minutes ago
20 DMA Support 27 minutes ago
Down 1% 27 minutes ago
Fell Below Previous Day's Low 27 minutes ago
50 DMA Resistance about 19 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Edwards Lifesciences Corporation Description

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers surgical heart valve therapy products, such as tissue heart valves and repair products, which are used to replace or repair a patient's diseased or defective heart valve; and produces pericardial and porcine valves. Its surgical heart valve therapy products include Carpentier-Edwards PERIMOUNT pericardial valve that comprise PERIMOUNT Magna Ease valves for aortic and mitral replacement; ThruPort systems that enable minimal incision valve surgery; and protection cannulae used during cardiac surgery in venous drainage, aortic perfusion, venting, and cardioplegia delivery. The company also provides transcatheter heart valves portfolio that includes technologies designed to treat heart valve disease using catheter-based approaches, as well as critical care products, such as hemodynamic monitoring systems to measure a patient's heart function in surgical and intensive care settings; Swan-Ganz line of pulmonary artery catheters and PreSep continuous venous oximetry catheters for measuring central venous oxygen saturation; VolumeView sensor-catheters; FloTrac continuous cardiac output monitoring system, a minimally invasive cardiac monitoring technology for goal-directed fluid optimization; and EV1000 clinical monitoring platform, which displays a patient's physiologic status. Its critical care products also include disposable pressure monitoring devices and closed blood sampling systems to help protect both patients and clinicians from the risk of infection; and products used to treat endolumenal occlusive disease, including balloon-tipped, catheter-based embolectomy products, surgical clips, and clamps. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California.


Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Surgery Catheter Irvine Infection Catheters Oxygen Drainage Artery Perfusion Incision Cardiac Surgery Repair Products Cannula Cardiac Monitoring Heart Disease Heart Valve Care Products Ricard Cardiac Output Edwards Embolectomy Heart Heart Valves Edwards Lifesciences Heart Valve Disease Valvular Heart Disease

Is EW a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 92.08
52 Week Low 51.5067
Average Volume 2,375,917
200-Day Moving Average 80.18
50-Day Moving Average 86.64
20-Day Moving Average 85.30
10-Day Moving Average 84.68
Average True Range 2.02
ADX 11.26
+DI 23.60
-DI 20.14
Chandelier Exit (Long, 3 ATRs ) 82.15
Chandelier Exit (Short, 3 ATRs ) 87.67
Upper Bollinger Band 87.96
Lower Bollinger Band 82.64
Percent B (%b) 0.68
BandWidth 6.23
MACD Line -0.33
MACD Signal Line -0.40
MACD Histogram 0.0739
Fundamentals Value
Market Cap 53.77 Billion
Num Shares 623 Million
EPS 1.27
Price-to-Earnings (P/E) Ratio 68.21
Price-to-Sales 12.31
Price-to-Book 12.62
PEG Ratio 3.06
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 88.38
Resistance 3 (R3) 88.35 87.61 88.03
Resistance 2 (R2) 87.61 87.08 87.63 87.91
Resistance 1 (R1) 86.95 86.75 87.28 86.98 87.80
Pivot Point 86.21 86.21 86.38 86.23 86.21
Support 1 (S1) 85.55 85.68 85.88 85.58 84.76
Support 2 (S2) 84.81 85.35 84.83 84.65
Support 3 (S3) 84.15 84.81 84.53
Support 4 (S4) 84.18